A case with cerebral infarction accompanied by immune thrombocytopenia following mRNA-BNT162b2 (Pfizer-BioNTeck) COVID-19 vaccination
Journal of Geriatric Neurology · 2022
DOI: 10.53991/jgn.2022.00087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Geriatric Neurology, 2022. Verfasst von Sol Chae und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A 87-year-old woman presented with right hemiparesis and dysarthria. She had received the mRNA-BNT162b2 (Pfizer–BioNTech) 3 days ago. Initial blood and imaging test showed very low levels of platelets (20,000/μl) and acute MCA territorial embolic infarction with severe M1 stenosis. The several blood tests to find the cause including anti-platelet factor 4 antibody were unremarkable. The platelet count gradually increased up to 134,000/μl after treatment with intravenous steroid and anticoagulation. We reported cerebral infarction related to immune thrombocytopenia after receiving mRNA- coronavirus disease 2019 vaccine.
Zitieren
APA
Chae, S., Yun, D. M., Lim, S. M., & Lee, S. J. (2022). A case with cerebral infarction accompanied by immune thrombocytopenia following mRNA-BNT162b2 (Pfizer-BioNTeck) COVID-19 vaccination. Journal of Geriatric Neurology. https://doi.org/10.53991/jgn.2022.00087
Vancouver
Chae S, Yun DM, Lim SM, Lee SJ. A case with cerebral infarction accompanied by immune thrombocytopenia following mRNA-BNT162b2 (Pfizer-BioNTeck) COVID-19 vaccination. Journal of Geriatric Neurology. 2022. doi:10.53991/jgn.2022.00087
BibTeX
@article{Chae2022,
author = {Chae, Sol and Yun, Dong Min and Lim, Sung Min and Lee, Soo Joo},
title = {A case with cerebral infarction accompanied by immune thrombocytopenia following mRNA-BNT162b2 (Pfizer-BioNTeck) COVID-19 vaccination},
journal = {Journal of Geriatric Neurology},
year = {2022},
doi = {10.53991/jgn.2022.00087}
}
EUVIMED